CLU and Alzheimer disease: Our findings suggest that CSF clusterin levels are associated with changes in pathology related to AD: decreased CSF clusterin levels in early AD (MCI) is associated with abnormal Aβ pathology, previous research has suggested that the correlation between clusterin and CSF Aβ42 may be related to the specific interaction of clusterin with amyloid.